BioMedExperts a Premier Online Scientific Social Network Community

Collexis Holdings, Inc.Dell and Collexis Holdings, Inc., plan to launch today BioMedExperts - an innovative social networking community that will promote collaborative medical research and development. BioMedExperts will allow health care and life sciences professionals to easily connect and collaborate with each other, as well as conduct research by providing 1.4 million biomedical experts with 12 million pre-established network connections from more than 120 countries. The site also provides the ability to analyze all associated professional connections within the network and view scientific publications.

As part of the initiative, Dell will provide computer hardware to power the Collexis-designed BioMedExperts. Dell will also provide marketing support for BioMedExperts, including co-branded marketing efforts and promotions at major life science research conferences.

"Dell believes connecting biomedical scientists through online communities will drive true innovation and progress and is critical to the future of biomedical research. BioMedExperts is a cutting-edge tool that can link researchers from around the globe and enable this new level of collaboration," said James Coffin, Ph.D., vice president and general manager, Dell Health Care and Life Sciences. "The Collexis technology and the BioMedExperts professional community is an example of how technology can connect scientists, enabling them to attack new and more complex cross-disciplinary biological problems. This next-generation professional network platform is a prime example of how Dell works with the world’s most innovative technology companies to drive thought leadership and leading-edge research collaboration."

Bill Kirkland, CEO of Collexis, said, "Collexis is excited about working with an industry leader like Dell, which has an intense focus on success in the life sciences market. We are also delighted to have their support in raising awareness of BioMedExperts among the growing number of biomedical researchers and health care providers who are finding online communities to be a perfect way to share, collaborate and discuss their work and discover new research opportunities. And we see this tool becoming even more valuable to researchers as we add millions of profiles during the next couple of months."

For further information, please visit:
http://www.biomedexperts.com

Related news articles:

About Dell
Dell Inc. (NASDAQ: DELL) listens to customers and delivers innovative technology and services they trust and value. Uniquely enabled by its direct business model, Dell is a leading global systems and services company and No. 34 on the Fortune 500. For more information, visit www.dell.com.

About Collexis Holdings, Inc.
Named a Trend-Setting product of 2007 by KMWorld, Collexis Holdings, Inc., a leading developer of high definition search and knowledge discovery software since 1999, is headquartered in Columbia, South Carolina (USA), with three subsidiaries: Collexis Inc. in Columbia, South Carolina, USA; Collexis, B.V. in Geldermalsen, The Netherlands; and SyynX Solutions GmBH in Cologne, Germany. Collexis proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, websites, e-mails and other digitized content and matches them with a comprehensive list of pre-defined “fingerprinted” concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as “finding needles in many haystacks.” Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect. Collexis’s current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; University of California, San Francisco; University of South Carolina; Erasmus University Library; Merck & Co.; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense. Collexis shares of common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, please visit www.collexis.com.

Most Popular Now

Adults don't Trust Health Care to U…

A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care...

AI Unlocks Genetic Clues to Personalize …

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes - insights that could help doctors tailor...

The 10 Year Health Plan: What do We Need…

Opinion Article by Piyush Mahapatra, Consultant Orthopaedic Surgeon and Chief Innovation Officer at Open Medical. There is a new ten-year plan for the NHS. It will "focus efforts on preventing, as...

People's Trust in AI Systems to Mak…

Psychologists warn that AI's perceived lack of human experience and genuine understanding may limit its acceptance to make higher-stakes moral decisions. Artificial moral advisors (AMAs) are systems based on artificial...

Deep Learning to Increase Accessibility…

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

To be Happier, Take a Vacation... from Y…

Today, nearly every American - 91% - owns a cellphone that can access the internet, according to the Pew Research Center. In 2011, only about one-third did. Another study finds...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...

Researchers Find Telemedicine may Help R…

Low-value care - medical tests and procedures that provide little to no benefit to patients - contributes to excess medical spending and both direct and cascading harms to patients. A...

AI Revolutionizes Glaucoma Care

Imagine walking into a supermarket, train station, or shopping mall and having your eyes screened for glaucoma within seconds - no appointment needed. With the AI-based Glaucoma Screening (AI-GS) network...